Natural Product Derivatives For Inhibiting Cellular Necroptosis, Ferroptosis And Oxytosis - Archive ouverte HAL Accéder directement au contenu
Brevet Année : 2022

Natural Product Derivatives For Inhibiting Cellular Necroptosis, Ferroptosis And Oxytosis

Résumé

The present invention relates to a compound of the following general formula: ( I ) :or a pharmaceutically acceptable salt and / or solvate thereof , for use as drug , particularly intended for inhibiting a programmed cell death route selected from the group consisting of ferroptosis , oxytosis and cellular necroptosis . The present invention also relates to a compound of general formula ( 1 ) for use as a drug for neuroprotection as well as for preventing and / or treating disorders associated with cellular necroptosis or ferroptosis . The present invention also relates to a pharmaceutical composition comprising a compound of general formula ( I ) , or a pharmaceutically acceptable salt and / or solvate thereof . The present invention also encompasses the use of a compound of the general formula ( I ) for organs preservation.
Fichier non déposé

Dates et versions

hal-03870690 , version 1 (24-11-2022)

Identifiants

  • HAL Id : hal-03870690 , version 1

Citer

Stéphane Bach, Marie-Thérèse Dimanche-Boitrel, Claire Delehouzé, Thierry Hauet. Natural Product Derivatives For Inhibiting Cellular Necroptosis, Ferroptosis And Oxytosis. United States, Patent n° : US 2022/0096426 A1. 2022. ⟨hal-03870690⟩
30 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More